{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:52:58Z","timestamp":1778701978494,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,12,20]],"date-time":"2002-12-20T00:00:00Z","timestamp":1040342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1038\/sj.npp.1300131","type":"journal-article","created":{"date-parts":[[2003,5,7]],"date-time":"2003-05-07T15:34:40Z","timestamp":1052321680000},"page":"979-984","source":"Crossref","is-referenced-by-count":51,"title":["Effects of Alprazolam on Cholecystokinin-Tetrapeptide-Induced Panic and Hypothalamic\u2013Pituitary\u2013Adrenal-Axis Activity: A Placebo-Controlled Study"],"prefix":"10.1038","volume":"28","author":[{"given":"P","family":"Zwanzger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Eser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Aicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Sch\u00fcle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T C","family":"Baghai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Padberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Ella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-J","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,12,20]]},"reference":[{"key":"BF1300131_CR1","doi-asserted-by":"publisher","first-page":"167S","DOI":"10.1016\/S0006-3223(00)01078-7","volume":"49","author":"JL Abelson","year":"2001","unstructured":"Abelson JL, Young EA, Liberzon I (2001). Hypothalamic\u2013pituitary\u2013adrenal response to pharmacological activation is cognitively manipulable. Biol Psychiatry 49: 167S.","journal-title":"Biol Psychiatry"},{"key":"BF1300131_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/archpsyc.1988.01800290027004","volume":"45","author":"JC Ballenger","year":"1988","unstructured":"Ballenger JC, Burrows GD, DuPont RL, Lesser IM, Noyes Jr R, Pecknold JC, Rifkin A, Swinson RP (1988). Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry 45: 413\u2013422.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300131_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0014-2999(88)90703-0","volume":"151","author":"A Bouthillier","year":"1988","unstructured":"Bouthillier A, de Montigny C (1988). Long-term benzodiazepine treatment reduces neuronal responsiveness to cholecystokinin: an electrophysiological study in the rat. Eur J Pharmacol 151: 135\u2013138.","journal-title":"Eur J Pharmacol"},{"key":"BF1300131_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/312363a0","volume":"312","author":"J Bradwejn","year":"1984","unstructured":"Bradwejn J, de Montigny C (1984). Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones. Nature 312: 363\u2013364.","journal-title":"Nature"},{"key":"BF1300131_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1176\/ajp.151.2.261","volume":"151","author":"J Bradwejn","year":"1994","unstructured":"Bradwejn J, Koszycki D (1994). Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients. Am J Psychiatry 151: 261\u2013263.","journal-title":"Am J Psychiatry"},{"key":"BF1300131_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF02244846","volume":"114","author":"J Bradwejn","year":"1994","unstructured":"Bradwejn J, Koszycki D, Couetoux du TA, Paradis M, Bourin M (1994). Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers. Psychopharmacology 114: 257\u2013261.","journal-title":"Psychopharmacology"},{"key":"BF1300131_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/070674379003500115","volume":"35","author":"J Bradwejn","year":"1990","unstructured":"Bradwejn J, Koszycki D, Meterissian G (1990). Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry 35: 83\u201385.","journal-title":"Can J Psychiatry"},{"key":"BF1300131_CR8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1176\/ajp.149.7.962","volume":"149","author":"J Bradwejn","year":"1992","unstructured":"Bradwejn J, Koszycki D, Payeur R, Bourin M, Borthwick H (1992). Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings. Am J Psychiatry 149: 962\u2013964.","journal-title":"Am J Psychiatry"},{"key":"BF1300131_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/archpsyc.1991.01810310021005","volume":"48","author":"J Bradwejn","year":"1991","unstructured":"Bradwejn J, Koszycki D, Shriqui C (1991). Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch Gen Psychiatry 48: 603\u2013610.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300131_CR10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/0006-3223(92)90177-2","volume":"32","author":"A Breier","year":"1992","unstructured":"Breier A, Davis O, Buchanan R, Listwak SJ, Holmes C, Pickar D Goldstein (1992). Effects of alprazolam on pituitary\u2013adrenal and catecholaminergic responses to metabolic stress in humans. Biol Psychiatry 32: 880\u2013890.","journal-title":"Biol Psychiatry"},{"key":"BF1300131_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0165-0327(86)90001-7","volume":"10","author":"P Christensen","year":"1986","unstructured":"Christensen P, Gram LF, Kragh-Sorensen P, Nielsen S (1986). Afternoon cortisol levels before (spontaneous) and after suppression with dexamethasone or oxazepam in depressed patients. J Affect Disord 10: 171\u2013176.","journal-title":"J Affect Disord"},{"key":"BF1300131_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/archpsyc.1989.01810060031006","volume":"46","author":"C de Montigny","year":"1989","unstructured":"de Montigny C (1989). Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. Arch Gen Psychiatry 46: 511\u2013517.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300131_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0022-3956(90)90042-O","volume":"24","author":"EB de Souza","year":"1990","unstructured":"de Souza EB (1990). Neuroendocrine effects of benzodiazepines. J Psychiatr Res 24: 111\u2013119.","journal-title":"J Psychiatr Res"},{"key":"BF1300131_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0165-1781(87)90002-3","volume":"20","author":"DJ Dillon","year":"1987","unstructured":"Dillon DJ, Gorman JM, Liebowitz MR, Fyer AJ, Klein DF (1987). Measurement of lactate-induced panic and anxiety. Psychiatry Res 20: 97\u2013105.","journal-title":"Psychiatry Res"},{"key":"BF1300131_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0014-2999(90)90594-V","volume":"180","author":"J Harro","year":"1990","unstructured":"Harro J, Lang A, Vasar E (1990). Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain. Eur J Pharmacol 180: 77\u201383.","journal-title":"Eur J Pharmacol"},{"key":"BF1300131_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0165-6147(93)90020-K","volume":"14","author":"J Harro","year":"1993","unstructured":"Harro J, Vasar E, Bradwejn J (1993). CCK in animal and human research on anxiety. Trends Pharmacol Sci 14: 244\u2013249.","journal-title":"Trends Pharmacol Sci"},{"key":"BF1300131_CR17","first-page":"A76","volume":"60","author":"RM Hirschfeld","year":"1996","unstructured":"Hirschfeld RM (1996). Placebo response in the treatment of panic disorder. Bull Menninger Clin 60: A76\u2013A86.","journal-title":"Bull Menninger Clin"},{"key":"BF1300131_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G","volume":"8","author":"D Koszycki","year":"1998","unstructured":"Koszycki D, Zacharko RM, Le Melledo JM, Bradwejn J (1998). Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers. Depress Anxiety 8: 1\u20137.","journal-title":"Depress Anxiety"},{"key":"BF1300131_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0006-3223(97)00536-2","volume":"44","author":"JM Le Melledo","year":"1998","unstructured":"Le Melledo JM, Bradwejn J, Koszycki D, Bichet DG, Bellavance F (1998). The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms. Biol Psychiatry 44: 364\u2013366.","journal-title":"Biol Psychiatry"},{"key":"BF1300131_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0922-4106(93)90129-W","volume":"245","author":"M Rattray","year":"1993","unstructured":"Rattray M, Singhvi S, Wu PY, Andrews N, File SE (1993). Benzodiazepines increase preprocholecystokinin messenger RNA levels in rat brain. Eur J Pharmacol 245: 193\u2013196.","journal-title":"Eur J Pharmacol"},{"key":"BF1300131_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0006-3223(91)90072-T","volume":"30","author":"PP Roy-Byrne","year":"1991","unstructured":"Roy-Byrne PP, Cowley DS, Hommer D, Ritchie J, Greenblatt D, Nemeroff C (1991). Neuroendocrine effects of diazepam in panic and generalized anxiety disorders. Biol Psychiatry 30: 73\u201380.","journal-title":"Biol Psychiatry"},{"key":"BF1300131_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/0006-3223(92)90275-5","volume":"31","author":"MA Schuckit","year":"1992","unstructured":"Schuckit MA, Hauger R, Klein JL (1992). Adrenocorticotropin hormone response to diazepam in healthy young men. Biol Psychiatry 31: 661\u2013669.","journal-title":"Biol Psychiatry"},{"key":"BF1300131_CR23","first-page":"332","volume":"22","author":"J Shlik","year":"1997","unstructured":"Shlik J, Aluoja A, Vasar V, Vasar E, Podar T, Bradwejn J (1997). Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. J Psychiatry Neurosci 22: 332\u2013340.","journal-title":"J Psychiatry Neurosci"},{"key":"BF1300131_CR24","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1523\/JNEUROSCI.04-10-02590.1984","volume":"4","author":"P Somogyi","year":"1984","unstructured":"Somogyi P, Hodgson AJ, Smith AD, Nunzi MG, Gorio A, Wu JY (1984). Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin-immunoreactive material. J Neurosci 4: 2590\u20132603.","journal-title":"J Neurosci"},{"key":"BF1300131_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0893-133X(99)00115-3","volume":"22","author":"A Strohle","year":"2000","unstructured":"Strohle A, Holsboer F, Rupprecht R (2000). Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder. Neuropsychopharmacology 22: 251\u2013256.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300131_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s002130050201","volume":"129","author":"H van Megen","year":"1997","unstructured":"van Megen H, Westenberg HG, den Boer J, Slaap B, Scheepmakers A (1997). Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks. Psychopharmacology 129: 357\u2013364.","journal-title":"Psychopharmacology"},{"key":"BF1300131_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0924-977X(96)00038-7","volume":"6","author":"HJ van Megen","year":"1996","unstructured":"van Megen HJ, Westenberg HG, den Boer JA, Kahn RS (1996). Cholecystokinin in anxiety. Eur Neuropsychopharmacol 6: 263\u2013280.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BF1300131_CR28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/archpsyc.58.4.371","volume":"58","author":"K Wiedemann","year":"2001","unstructured":"Wiedemann K, Jahn H, Yassouridis A, Kellner M (2001). Anxiolytic like effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings. Arch Gen Psychiatry 58: 371\u2013377.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300131_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0006-8993(87)90784-0","volume":"406","author":"TL Yaksh","year":"1987","unstructured":"Yaksh TL, Furui T, Kanawati IS, Go VL (1987). Release of cholecystokinin from rat cerebral cortex in vivo: role of GABA and glutamate receptor systems. Brain Res 406: 207\u2013214.","journal-title":"Brain Res"},{"key":"BF1300131_CR30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0893-133X(01)00266-4","volume":"25","author":"P Zwanzger","year":"2001","unstructured":"Zwanzger P, Baghai T, Sch\u00fcle C, Str\u00f6hle A, Padberg F, Kathmann N, Schwarz M, M\u00f6ller HJ, Rupprecht R (2001). Vigabatrin decreases cholecystokinin tetrapeptide (CCK-4) induced panic in healthy volunteers. Neuropsychopharmacology 25: 699\u2013703.","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300131","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:43:21Z","timestamp":1684219401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,20]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["BF1300131"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300131","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,20]]}}}